Similar articles

• Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial.

  Pepperell JC, Ramdassingh-Dow S, Crosthwaite N, Mullins R, Jenkinson C, Stradling JR, Davies RJ. Pepperell JC, et al. Lancet. 2002 Jan 19;359(9302):204-10. doi: 10.1016/S0140-6736(02)07445-7. Lancet. 2002. PMID: 11812555 Clinical Trial.
• [Nasal CPAP treatment and hypertension and altered cardiovascular variability associated with obstructive sleep apnea (OSA)].

  Otsuka K. Otsuka K. Nihon Rinsho. 2001 May;59(5):983-91. Nihon Rinsho. 2001. PMID: 11392003 Review. Japanese.
• Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial.

  Durán-Cantolla J, Aizpuru F, Montserrat JM, Ballester E, Terán-Santos J, Aguirregomoscorta JI, Gonzalez M, Lloberes P, Masa JF, De La Peña M, Carrizo S, Mayos M, Barbé F; Spanish Sleep and Breathing Group. Durán-Cantolla J, et al. BMJ. 2010 Nov 24;341:c5991. doi: 10.1136/bmj.c5991. BMJ. 2010. PMID: 21106625 Clinical Trial.
• Ambulatory blood pressure after sleep apnoea treatment.

  Teramoto S, Kume H, Matsuse T. Teramoto S, et al. Lancet. 2002 Jul 27;360(9329):341; author reply 341-2. doi: 10.1016/S0140-6736(02)09530-2. Lancet. 2002. PMID: 12147401 No abstract available.
• Treatment of obstructive sleep apnea syndrome.

  Freedman N. Freedman N. Clin Chest Med. 2010 Jun;31(2):187-201. doi: 10.1016/j.ccm.2010.02.012. Clin Chest Med. 2010. PMID: 20488281 Review.